Hawkins, Inc. (NASDAQ:HWKN) Announces $0.19 Quarterly Dividend

Hawkins, Inc. (NASDAQ:HWKN) declared a quarterly dividend on Wednesday, January 28th. Investors of record on Friday, February 13th will be paid a dividend of 0.19 per share by the specialty chemicals company on Friday, February 27th. This represents a c) dividend on an annualized basis and a yield of 0.5%. The ex-dividend date of this dividend is Friday, February 13th.

Hawkins has increased its dividend by an average of 0.1%per year over the last three years and has raised its dividend annually for the last 20 consecutive years. Hawkins has a dividend payout ratio of 16.2% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect Hawkins to earn $4.26 per share next year, which means the company should continue to be able to cover its $0.76 annual dividend with an expected future payout ratio of 17.8%.

Hawkins Stock Performance

NASDAQ HWKN traded down $13.35 during trading hours on Thursday, hitting $140.40. The company had a trading volume of 178,926 shares, compared to its average volume of 122,139. The company has a quick ratio of 1.49, a current ratio of 2.43 and a debt-to-equity ratio of 0.53. The firm has a market cap of $2.93 billion, a P/E ratio of 35.23, a price-to-earnings-growth ratio of 2.38 and a beta of 0.86. Hawkins has a fifty-two week low of $98.30 and a fifty-two week high of $186.15. The business has a fifty day simple moving average of $144.14 and a 200-day simple moving average of $156.57.

Hawkins (NASDAQ:HWKN) last released its quarterly earnings results on Wednesday, January 28th. The specialty chemicals company reported $0.72 EPS for the quarter, missing the consensus estimate of $0.75 by ($0.03). Hawkins had a return on equity of 17.42% and a net margin of 7.95%.The firm had revenue of $244.08 million for the quarter, compared to the consensus estimate of $252.51 million. Equities analysts predict that Hawkins will post 4 EPS for the current year.

Insider Activity at Hawkins

In other news, VP Drew M. Grahek bought 1,587 shares of the company’s stock in a transaction that occurred on Monday, November 3rd. The shares were purchased at an average price of $126.34 per share, with a total value of $200,501.58. Following the completion of the acquisition, the vice president directly owned 39,640 shares in the company, valued at approximately $5,008,117.60. This trade represents a 4.17% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 4.10% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Hawkins

A number of institutional investors and hedge funds have recently added to or reduced their stakes in HWKN. Salomon & Ludwin LLC bought a new stake in shares of Hawkins in the 3rd quarter worth $27,000. BNP PARIBAS ASSET MANAGEMENT Holding S.A. acquired a new position in Hawkins during the second quarter worth about $31,000. First Horizon Corp bought a new stake in Hawkins in the third quarter worth about $34,000. Sound Income Strategies LLC bought a new stake in Hawkins in the fourth quarter worth about $34,000. Finally, Aster Capital Management DIFC Ltd lifted its holdings in Hawkins by 62.2% in the 3rd quarter. Aster Capital Management DIFC Ltd now owns 300 shares of the specialty chemicals company’s stock valued at $55,000 after acquiring an additional 115 shares during the last quarter. 69.71% of the stock is owned by institutional investors.

About Hawkins

Hawkins, Inc (NASDAQ: HWKN) is a specialty chemical company that produces and distributes water-treatment and industrial chemicals across North America. Founded in 1938 and headquartered in Roseville, Minnesota, the company has built a network of manufacturing facilities and distribution centers that serve municipal, industrial and commercial customers. As a publicly traded entity, Hawkins leverages its long-standing presence in the chemical distribution industry to provide tailored solutions for complex water-treatment challenges and specialty chemical needs.

Hawkins’ product portfolio encompasses a wide range of chemicals, including sodium hypochlorite, sodium hydroxide, hydrogen peroxide, chlorine, acids and specialty blends.